Company / Total Assets
CG Oncology, Inc. Total Assets History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$791.6M
FY2025
5-year range
$199.3M / $791.6M
FY2023-FY2025
Trend
+4.9%
vs FY2024
Sector context
#96 of 214
Health Care
What the data says
At $792M, CG Oncology, Inc.'s total assets ranks #96 of 214 in the Health Care sector. Improved from $199M to $792M over the past 2 years.
Based on SEC 10-K filings.
$792M in FY2025.
Improved from $199M to $792M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#96 of 214 in Health CareTop 45% of 214This company $791.6M Sector average $7.5B
▼
-89.4% below sector average
Key checks
Key Insights
- In FY2025, total assets increased 4.9% year-over-year.
- Ranks #96 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 8.02 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $791.6M | +4.9% |
| FY2024 | $754.8M | +278.7% |
| FY2023 | $199.3M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026